-
Several major UK food and beverage brands report financial losses amid rising costs and industry pressures. Pret a Manger plans to test meal deals to boost sales, while Tesco and others increase prices. Meanwhile, the parent companies of Pret and Costa face impairments and potential sales, reflecting broader economic challenges.
-
Recent UK regulations restrict free refills of sugary drinks in hospitality venues and ban multi-buy deals on unhealthy foods to combat rising obesity. These measures, effective from October 2025, aim to promote healthier choices and reduce health risks like diabetes and heart disease, amid ongoing industry adjustments.
-
On December 1-2, 2025, WHO issued its first guidelines recommending long-term use of GLP-1 drugs like Wegovy and Mounjaro for obesity treatment, recognizing obesity as a chronic disease. The US government finalized deals lowering prices for these drugs under Medicare and Medicaid, expanding coverage to more patients. Despite benefits, studies show weight and health gains reverse if treatment stops, highlighting need for ongoing care.
-
Local leaders in Charlotte and Chicago are preparing for potential federal immigration enforcement actions amid reports of planned operations. Community groups are training volunteers to protest and document actions, citing fears of invasion and racial profiling. No formal notifications have been received, but tensions are high as officials emphasize the city’s diverse immigrant populations.
-
Bank of England's Greene signals potential rate cuts if economic weakness persists, citing weak employment and consumption data. Markets expect a rate cut to 3.75% by end-2025 amid mixed economic signals, with inflation and wage growth key factors.
-
San Francisco has filed a lawsuit against 11 major food companies, accusing them of marketing ultra-processed foods that contribute to health issues like obesity and diabetes. The city seeks penalties, consumer education, and restrictions on marketing, especially to children, citing scientific links to chronic illnesses.